The efficacy of skin-moisturizing agents for radiation dermatitis and basic information associated with radiation dermatitis

The efficacy of skin-moisturizing agents for radiation dermatitis and basic information associated with radiation dermatitis - The efficacy of skin-moisturizing agents for radiation dermatitis

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005532

Enrollment

125

Registered

2011-04-29

Start date

2011-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Application of heparinoid on the irradiated skin twice a day two weeks after the completion of whole breast irradiation No application of heparinoid and other skin-moisturizing agents on the irradia

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1.Breast cancer patients who are to be treated with whole breast irradiation 2. no previous radiotherapy 3. written in informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with widespread skin complications 2. Patients who have past history of collagen vascular diseases 3. Patients who were sensitive to heparinoid 4. Patients who were judged unsuitable for this study by the investigator.

Design outcomes

Primary

Measure	Time frame
Change of ratio of stratum corneum hydration after four weeks from end of radiotherapy	—

Secondary

Measure	Time frame
Sebaceous volume, activities of sebaceous glands, objective symptom, subjective symptom, sebaceous component	—

Countries

Japan

Contacts

Public ContactMami Ogita

St Luke's international Hospital Department of Radiation Oncology

keikoak@luke.or.jp03-5550-7006

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026